Early correction of NMDAR function improves autistic-like social behaviors in adult Shank2−/− mice

Background: Autism spectrum disorders (ASD) involve neurodevelopmental dysregulations that lead to visible symptoms at early stages of life. Many ASD-related mechanisms suggested by animal studies are supported by demonstrated improvement in autistic-like phenotypes in adult animals following experimental reversal of dysregulated mechanisms. However, whether such mechanisms also act at earlier stages to cause autistic-like phenotypes is unclear. Methods: We used Shank2−/− mice carrying a mutation identified in human ASD (exons 6 and 7 deletion) and combined electrophysiological and behavioral analyses to see if early pathophysiology at pup stages is different from late pathophysiology at juvenile and adult stages, and correcting early pathophysiology can normalize late pathophysiology and abnormal behaviors in juvenile and adult mice. Results: Early correction of a dysregulated mechanism in young mice prevents manifestation of autistic-like social behaviors in adult mice. Shank2−/− mice, known to display N-methyl-Daspartate receptor (NMDAR) hypofunction and autistic-like behaviors at post-weaning stages after postnatal day 21 (P21), show the opposite synaptic phenotype—NMDAR hyperfunction—at an earlier pre-weaning stage (~P14). Moreover, this NMDAR hyperfunction at P14 rapidly shifts to NMDAR hypofunction after weaning (~P24). Chronic suppression of the early NMDAR hyperfunction by the NMDAR antagonist memantine (P7-21) prevents NMDAR hypofunction and autistic-like social behaviors from manifesting at later stages (~P28 and P56). Conclusions: Early NMDAR hyperfunction leads to late NMDAR hypofunction and autisticlike social behaviors in Shank2−/− mice, and early correction of NMDAR dysfunction has the long-lasting effect of preventing autistic-like social behaviors from developing at later stages.

[1]  M. Kas,et al.  Heterogeneity of Cell Surface Glutamate and GABA Receptor Expression in Shank and CNTN4 Autism Mouse Models , 2018, Front. Mol. Neurosci..

[2]  Eunjoon Kim,et al.  Cell-Type-Specific Shank2 Deletion in Mice Leads to Differential Synaptic and Behavioral Phenotypes , 2018, The Journal of Neuroscience.

[3]  C. Verpelli,et al.  SHANK genes in autism: Defining therapeutic targets , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[4]  Henry H Yin,et al.  Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers. , 2017, JCI insight.

[5]  Shireene Kalbassi,et al.  Male and Female Mice Lacking Neuroligin-3 Modify the Behavior of Their Wild-Type Littermates , 2017, eNeuro.

[6]  H. Hirase,et al.  Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice , 2017, Science Advances.

[7]  Eunjoon Kim,et al.  Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders , 2017, Biological Psychiatry.

[8]  Masaaki Sato,et al.  Hippocampus-Dependent Goal Localization by Head-Fixed Mice in Virtual Reality , 2017, eNeuro.

[9]  G. Feng,et al.  SHANK proteins: roles at the synapse and in autism spectrum disorder , 2017, Nature Reviews Neuroscience.

[10]  Min Goo Lee,et al.  Enhancing inhibitory synaptic function reverses spatial memory deficits in Shank2 mutant mice , 2017, Neuropharmacology.

[11]  Yong Ho Kim,et al.  A critical role of spinal Shank2 proteins in NMDA-induced pain hypersensitivity , 2017, Molecular pain.

[12]  Dongwon Lee,et al.  Cerebellar Shank2 Regulates Excitatory Synapse Density, Motor Coordination, and Specific Repetitive and Anxiety-Like Behaviors , 2016, The Journal of Neuroscience.

[13]  Martijn Schonewille,et al.  Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice , 2016, Nature Communications.

[14]  T. Bourgeron,et al.  Recording Mouse Ultrasonic Vocalizations to Evaluate Social Communication , 2016, Journal of visualized experiments : JoVE.

[15]  M. Zhuo,et al.  Reduced acute nociception and chronic pain in Shank2−/− mice , 2016, Molecular pain.

[16]  D. Geschwind,et al.  Advancing the understanding of autism disease mechanisms through genetics , 2016, Nature Medicine.

[17]  Zhong Xuan,et al.  Altered Striatal Synaptic Function and Abnormal Behaviour in Shank3 Exon4‐9 Deletion Mouse Model of Autism , 2016, Autism research : official journal of the International Society for Autism Research.

[18]  K. Misura,et al.  Whole-genome sequencing in multiplex families with psychoses reveals mutations in the SHANK2 and SMARCA1 genes segregating with illness , 2016, Molecular Psychiatry.

[19]  Neville E. Sanjana,et al.  Mice with Shank3 Mutations Associated with ASD and Schizophrenia Display Both Shared and Distinct Defects , 2016, Neuron.

[20]  C. Verpelli,et al.  Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders , 2015, Journal of neurochemistry.

[21]  K. Roche,et al.  Dynamic Regulation of N-Methyl-d-aspartate (NMDA) and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors by Posttranslational Modifications* , 2015, The Journal of Biological Chemistry.

[22]  Guoping Feng,et al.  Modeling psychiatric disorders for developing effective treatments , 2015, Nature Medicine.

[23]  T. Bourgeron From the genetic architecture to synaptic plasticity in autism spectrum disorder , 2015, Nature Reviews Neuroscience.

[24]  J. Costas The role of SHANK2 rare variants in schizophrenia susceptibility , 2015, Molecular Psychiatry.

[25]  M. Rietschel,et al.  Rare SHANK2 variants in schizophrenia , 2015, Molecular Psychiatry.

[26]  S. Nelson,et al.  Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders , 2015, Neuron.

[27]  C. Powell,et al.  Neuroligin 1 modulates striatal glutamatergic neurotransmission in a pathway and NMDAR subunit-specific manner , 2015, Front. Synaptic Neurosci..

[28]  R. Huganir,et al.  Glutamate synapses in human cognitive disorders. , 2015, Annual review of neuroscience.

[29]  J. Crawley,et al.  In tribute to Bob Blanchard: Divergent behavioral phenotypes of 16p11.2 deletion mice reared in same-genotype versus mixed-genotype cages , 2015, Physiology & Behavior.

[30]  M. Schmeisser Translational neurobiology in Shank mutant mice--model systems for neuropsychiatric disorders. , 2015, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[31]  C. Powell,et al.  Autism-Associated Insertion Mutation (InsG) of Shank3 Exon 21 Causes Impaired Synaptic Transmission and Behavioral Deficits , 2015, The Journal of Neuroscience.

[32]  Yuji Kajiwara,et al.  Autism-like Deficits in Shank3-Deficient Mice Are Rescued by Targeting Actin Regulators. , 2015, Cell reports.

[33]  Eunjoon Kim,et al.  Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors , 2015, Front. Mol. Neurosci..

[34]  Eunjoon Kim,et al.  Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation , 2015, Nature Communications.

[35]  G. Rumbaugh,et al.  Syngap1 Haploinsufficiency Damages a Postnatal Critical Period of Pyramidal Cell Structural Maturation Linked to Cortical Circuit Assembly , 2015, Biological Psychiatry.

[36]  Eunjoon Kim,et al.  NMDA receptor dysfunction in autism spectrum disorders. , 2015, Current opinion in pharmacology.

[37]  M. Jung,et al.  Social deficits in IRSp53 mutant mice improved by NMDAR and mGluR5 suppression , 2015, Nature Neuroscience.

[38]  Elodie Ey,et al.  Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments , 2014, PLoS genetics.

[39]  S. Birnbaum,et al.  Autism‐Related Neuroligin‐3 Mutation Alters Social Behavior and Spatial Learning , 2014, Autism research : official journal of the International Society for Autism Research.

[40]  S. Chou,et al.  Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality , 2014, Nature Neuroscience.

[41]  T. Bourgeron,et al.  Neurobiology of autism gene products: towards pathogenesis and drug targets , 2014, Psychopharmacology.

[42]  K. Tye,et al.  Amygdala Inputs to the Ventral Hippocampus Bidirectionally Modulate Social Behavior , 2014, The Journal of Neuroscience.

[43]  G. Rosenberger,et al.  Dysfunction of SHANK2 and CHRNA7 in a patient with intellectual disability and language impairment supports genetic epistasis of the two loci , 2013, Clinical genetics.

[44]  P. Worley,et al.  Loss of Predominant Shank3 Isoforms Results in Hippocampus-Dependent Impairments in Behavior and Synaptic Transmission , 2013, The Journal of Neuroscience.

[45]  Elodie Ey,et al.  The Autism ProSAP1/Shank2 mouse model displays quantitative and structural abnormalities in ultrasonic vocalisations , 2013, Behavioural Brain Research.

[46]  Sharmila Banerjee-Basu,et al.  SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs) , 2013, Molecular Autism.

[47]  Zhen Yan,et al.  Shank3 Deficiency Induces NMDA Receptor Hypofunction via an Actin-Dependent Mechanism , 2013, The Journal of Neuroscience.

[48]  Chang Soon Choi,et al.  Pax6-Dependent Cortical Glutamatergic Neuronal Differentiation Regulates Autism-Like Behavior in Prenatally Valproic Acid-Exposed Rat Offspring , 2013, Molecular Neurobiology.

[49]  Qiang Zhou,et al.  NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease , 2013, Nature Reviews Neuroscience.

[50]  M. Ehlers,et al.  Modeling Autism by SHANK Gene Mutations in Mice , 2013, Neuron.

[51]  R. Nicoll,et al.  Activated CaMKII couples GluN2B and casein kinase 2 to control synaptic NMDA receptors. , 2013, Cell reports.

[52]  M. Bennett,et al.  Dysregulation of synaptic plasticity precedes appearance of morphological defects in a Pten conditional knockout mouse model of autism , 2013, Proceedings of the National Academy of Sciences.

[53]  M. Till,et al.  Breakpoint mapping by next generation sequencing reveals causative gene disruption in patients carrying apparently balanced chromosome rearrangements with intellectual deficiency and/or congenital malformations , 2013, Journal of Medical Genetics.

[54]  John Wei,et al.  A Discovery Resource of Rare Copy Number Variations in Individuals with Autism Spectrum Disorder , 2012, G3: Genes | Genomes | Genetics.

[55]  D. Horn,et al.  Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.

[56]  Gavin Rumbaugh,et al.  Pathogenic SYNGAP1 Mutations Impair Cognitive Development by Disrupting Maturation of Dendritic Spine Synapses , 2012, Cell.

[57]  Min Goo Lee,et al.  Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function , 2012, Nature.

[58]  Anne-Marie Le Sourd,et al.  Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2 , 2012, Nature.

[59]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[60]  Mark F Bear,et al.  Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. , 2012, Cold Spring Harbor perspectives in biology.

[61]  Elodie Ey,et al.  Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders , 2012, PLoS genetics.

[62]  S. Scherer,et al.  Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology , 2011, Human molecular genetics.

[63]  M. Sheng,et al.  The postsynaptic organization of synapses. , 2011, Cold Spring Harbor perspectives in biology.

[64]  Hailan Hu,et al.  Medial Prefrontal Cortex Bidirectional Control of Social Hierarchy by Synaptic Efficacy in , 2011 .

[65]  Lief E. Fenno,et al.  Neocortical excitation/inhibition balance in information processing and social dysfunction , 2011, Nature.

[66]  J. Silverman,et al.  Automated Three‐Chambered Social Approach Task for Mice , 2011, Current protocols in neuroscience.

[67]  Alcino J. Silva,et al.  Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders. , 2011, Trends in molecular medicine.

[68]  Mark J. Harris,et al.  Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication , 2010, Molecular autism.

[69]  R. Giorda,et al.  Olfactory Receptor-Related Duplicons Mediate a Microdeletion at 11q13.2q13.4 Associated with a Syndromic Phenotype , 2010, Molecular Syndromology.

[70]  J. Isaac,et al.  Casein Kinase 2 Regulates the NR2 Subunit Composition of Synaptic NMDA Receptors , 2010, Neuron.

[71]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[72]  C. Lord,et al.  Behavioural phenotyping assays for mouse models of autism , 2010, Nature Reviews Neuroscience.

[73]  T. Südhof,et al.  Neuroligin-1 Deletion Results in Impaired Spatial Memory and Increased Repetitive Behavior , 2010, The Journal of Neuroscience.

[74]  Huilin Li,et al.  The Postsynaptic Density Proteins Homer and Shank Form a Polymeric Network Structure , 2009, Cell.

[75]  T. Südhof Neuroligins and neurexins link synaptic function to cognitive disease , 2008, Nature.

[76]  Jill P. Mesirov,et al.  GSEA-P: a desktop application for Gene Set Enrichment Analysis , 2007, Bioinform..

[77]  Toshiyuki Someya,et al.  Altered Chemical Metabolites in the Amygdala-Hippocampus Region Contribute to Autistic Symptoms of Autism Spectrum Disorders , 2007, Biological Psychiatry.

[78]  Henry Markram,et al.  Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid , 2007, Proceedings of the National Academy of Sciences.

[79]  C. Hoogenraad,et al.  The postsynaptic architecture of excitatory synapses: a more quantitative view. , 2007, Annual review of biochemistry.

[80]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Kai Chang,et al.  The Synaptic Localization of NR2B-Containing NMDA Receptors Is Controlled by Interactions with PDZ Proteins and AP-2 , 2005, Neuron.

[82]  W. Gan,et al.  Development of Long-Term Dendritic Spine Stability in Diverse Regions of Cerebral Cortex , 2005, Neuron.

[83]  D. Amaral,et al.  The Amygdala Is Enlarged in Children But Not Adolescents with Autism; the Hippocampus Is Enlarged at All Ages , 2004, The Journal of Neuroscience.

[84]  K. Roche,et al.  Differential binding of the AP-2 adaptor complex and PSD-95 to the C-terminus of the NMDA receptor subunit NR2B regulates surface expression , 2003, Neuropharmacology.

[85]  M. Ehlers,et al.  An NMDA Receptor ER Retention Signal Regulated by Phosphorylation and Alternative Splicing , 2001, The Journal of Neuroscience.

[86]  Thomas R. Insel,et al.  Social amnesia in mice lacking the oxytocin gene , 2000, Nature Genetics.

[87]  P. Worley,et al.  Shank, a Novel Family of Postsynaptic Density Proteins that Binds to the NMDA Receptor/PSD-95/GKAP Complex and Cortactin , 1999, Neuron.